Literature DB >> 20038250

The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking.

Md Rowshon Alam1, Xin Ming, Vidula Dixit, Michael Fisher, Xiaoyuan Chen, Rudolph L Juliano.   

Abstract

We demonstrate that the biological effect of an oligonucleotide is influenced by its route of cellular uptake. Utilizing a splice-switching antisense oligonucleotide (SSO) and a sensitive reporter assay involving correction of RNA splicing, we examined induction of luciferase in cells treated either with various concentrations of an unconjugated ("free") SSO or an SSO conjugated to a bivalent RGD ligand that promotes binding to the alphavbeta3 integrin (RGD-SSO). Under conditions of equal accumulation in cells, the RGD-SSO consistently had a greater effect on luciferase induction than the unconjugated SSO. We determined that the RGD-SSO and the unconjugated SSO were internalized by distinct endocytotic pathways, suggesting that the route of internalization affects the magnitude of the biological response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20038250      PMCID: PMC2883474          DOI: 10.1089/oli.2009.0211

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  28 in total

1.  GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway.

Authors:  Shefali Sabharanjak; Pranav Sharma; Robert G Parton; Satyajit Mayor
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

Review 2.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

Authors:  Peter Sazani; Ryszard Kole
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways.

Authors:  Ramiro H Massol; Jakob E Larsen; Yukako Fujinaga; Wayne I Lencer; Tomas Kirchhausen
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

4.  p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.

Authors:  R M Touyz; G Yao; M T Quinn; P J Pagano; E L Schiffrin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-23       Impact factor: 8.311

5.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.

Authors:  Erwei Song; Pengcheng Zhu; Sang-Kyung Lee; Dipanjan Chowdhury; Steven Kussman; Derek M Dykxhoorn; Yi Feng; Deborah Palliser; David B Weiner; Premlata Shankar; Wayne A Marasco; Judy Lieberman
Journal:  Nat Biotechnol       Date:  2005-05-22       Impact factor: 54.908

6.  Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.

Authors:  S Parpal; M Karlsson; H Thorn; P Strålfors
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

Review 7.  Antisense oligonucleotide-based therapeutics for cancer.

Authors:  Nicholas M Dean; C Frank Bennett
Journal:  Oncogene       Date:  2003-12-08       Impact factor: 9.867

8.  Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae.

Authors:  Eva-Maria Damm; Lucas Pelkmans; Jürgen Kartenbeck; Anna Mezzacasa; Teymuras Kurzchalia; Ari Helenius
Journal:  J Cell Biol       Date:  2005-01-24       Impact factor: 10.539

9.  Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.

Authors:  John J Turner; Andrey A Arzumanov; Michael J Gait
Journal:  Nucleic Acids Res       Date:  2005-01-07       Impact factor: 16.971

10.  Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway.

Authors:  A E Aplin; R L Juliano
Journal:  J Cell Sci       Date:  1999-03       Impact factor: 5.285

View more
  37 in total

1.  Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA.

Authors:  Md Rowshon Alam; Xin Ming; Michael Fisher; Jeremy G Lackey; Kallanthottathil G Rajeev; Muthiah Manoharan; Rudy L Juliano
Journal:  Bioconjug Chem       Date:  2011-07-20       Impact factor: 4.774

Review 2.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

3.  Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes.

Authors:  Xin Ming; Katsuya Sato; Rudolph L Juliano
Journal:  J Control Release       Date:  2011-05-04       Impact factor: 9.776

4.  Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.

Authors:  Jonathan W Kotula; Elizabeth D Pratico; Xin Ming; Osamu Nakagawa; Rudolph L Juliano; Bruce A Sullenger
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 5.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

Review 6.  Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.

Authors:  R L Juliano; Xin Ming; Kyle Carver; Brian Laing
Journal:  Nucleic Acid Ther       Date:  2014-01-02       Impact factor: 5.486

7.  A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

Authors:  E Merit Reyes-Reyes; Yun Teng; Paula J Bates
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

8.  ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS.

Authors:  Amanda P Malefyt; S Patrick Walton; Christina Chan
Journal:  Nano Life       Date:  2012-09-01

Review 9.  Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.

Authors:  R L Juliano
Journal:  Nucleic Acid Ther       Date:  2018-04-30       Impact factor: 5.486

10.  Covalent conjugation of oligonucleotides with cell-targeting ligands.

Authors:  Md Rowshon Alam; Xin Ming; Osamu Nakagawa; Jian Jin; R L Juliano
Journal:  Bioorg Med Chem       Date:  2013-06-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.